Artemether Ameliorates Non-Alcoholic Steatohepatitis by Repressing Lipogenesis, Inflammation, and Fibrosis in Mice

Background: Non-alcoholic fatty liver disease (NAFLD) is a widespread disease, but no recognized drug treatment exists. Previous studies have shown that artemether (Art) can ameliorate carbon tetrachloride (CCl(4))–induced liver fibrosis in mice. This study sets out to observe the therapeutic impact...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jia, He, Xiaoyun, Huang, Xianghui, Zhang, Feng, Ren, Xinxin, Asakiya, Charles, Li, Yue, Huang, Kunlun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108288/
https://www.ncbi.nlm.nih.gov/pubmed/35586049
http://dx.doi.org/10.3389/fphar.2022.851342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108288/
https://www.ncbi.nlm.nih.gov/pubmed/35586049
http://dx.doi.org/10.3389/fphar.2022.851342

Ejemplares similares